Product
Ritivixibat
1 clinical trial
1 indication
Indication
Primary Sclerosing CholangitisClinical trial
An Open Label, Phase 2 Study to Evaluate the Effect of A3907 on Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics in Adults With Primary Sclerosing Cholangitis (PSC)Status: Recruiting, Estimated PCD: 2025-06-14